List view / Grid view
13 November 2015 | By Victoria White
A post-marketing surveillance study showed that treatment with Ofev in the real-world clinical setting had a safety profile consistent with that observed in clinical trials...
13 November 2015 | By Victoria White
The FDA has approved Harvoni for expanded use in patients with genotype 4, 5 and 6 chronic HCV infection and in patients co-infected with HIV...
13 November 2015 | By Victoria White
Roche plans to restructure its manufacturing network for small molecules to address current underutilisation as a result of its evolving portfolio...
13 November 2015 | By Victoria White
GBI Research says the rise will be driven primarily by growth in disease prevalence due to an aging global population...
Sartorius Stedim Biotech (SSB) BioOutsource today announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with an excellent opportunity to discuss the optimum assay design for rapid and accurate biosimilar characterisation…
12 November 2015 | By Victoria White
Almost half of all drugs reviewed as part of the study had at least one undisclosed Phase II or III trial...
12 November 2015 | By Victoria White
The data reveals antibiotic prescribing hotspots and interesting correlations against areas of deprivation. It also shows seasonal variation in antibiotic prescribing...
12 November 2015 | By Victoria White
FLU-v is a peptide-based vaccine that stimulates a cytotoxic T lymphocyte and non-neutralising antibody response against influenza. FLU-v may have potential as a cross-protective vaccine for multiple strains of influenza...
12 November 2015 | By Victoria White
The additional financing will allow Kuros to further accelerate its efforts to bring its sealant products to market and to progress its lead orthobiologics product...
11 November 2015 | By Victoria White
The US National Academy of Medicine (NAM) recently announced the election of Dr Vasant “Vas” Narasimhan as a member of the Academy.
11 November 2015 | By Victoria White
The clinical trial, a first-in-man study, looked at the efficacy of ONO/GS-4059 in the treatment of Chronic Lymphocytic Leukaemia and Non-Hodgkin Lymphoma patients...
11 November 2015 | By Victoria White
The results showed that belimumab administered subcutaneously plus standard of care (SoC) demonstrated significantly greater reductions in disease activity compared to placebo plus SoC...
11 November 2015 | By Victoria White
The transaction will be the largest in LEO Pharma’s more than 100-year history in terms of incremental turnover...
11 November 2015 | By Victoria White
HM12525A is a novel biologic GLP-1/Glucagon dual receptor agonist to treat diabetes and obesity...
11 November 2015 | By Victoria White
The approval is for the treatment of people with BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma...
